Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01907126 · ClinicalTrials.gov registry record · NA

HIV/STI Risk Reduction for Incarcerated Women With Interpersonal Violence

A NA study of Sexual Assault and Unsafe Sex, sponsored by Brown University.

Completed
Registry status
NA
Development phase
42
Enrollment target
3
Study locations

NCT01907126: Completed NA study of Sexual Assault and Unsafe Sex, sponsored by Brown University.

NCT01907126 is a NA study of Sexual Assault and Unsafe Sex that has completed, run by Brown University. The registered enrollment target is 42 participants, below the 747-participant average among 12 other Sexual Assault trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01907126, a NA study of Sexual Assault and Unsafe Sex, has completed, sponsored by Brown University.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
3
Study locations

Study Summary

The pilot study aims to conduct a randomized pilot trial in a sample of 40 incarcerated women with lifetime interpersonal violence who are 6-10 weeks away from release to demonstrate the feasibility and acceptability of the proposed recruitment methods and research design, of the intervention training methods, of delivering the enhanced Women's Coop and nutrition control interventions. Per recent guidance from NIMH, the investigators will also examine 95% confidence intervals around differences between the proposed intervention and a dose-matched control condition (Nutrition Program), for the following outcomes through 8 months post prison release: reduced unprotected vaginal or anal sex occasions and fewer cases of vaginal trichomoniasis (primary); reduced interpersonal violence episodes, symptoms of PTSD and depression, and drug using/heavy drinking days (secondary); and increased affect management and social support (including effectiveness in obtaining substance use, mental health treatment and other resources) (tertiary).

Primary Outcome

The investigators will calculate effect sizes and confidence intervals for number of USOs. The number of USOs will be measured by the Timeline Follow Back (TLFB).

Interventions

  • BEHAVIORAL Nutrition Program (NP)
  • BEHAVIORAL Women's Prison CoOp (WPC)

Study Locations (3)

Massachusetts

  • Massachusetts CorrectionalInstitution - Framingham - Framingham
  • South Middlesex CorrectionalCenter - Framingham

Rhode Island

  • Adult Correctional Institution - Cranston

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2011-09
Est. Completion 2014-10
Phase NA
Brown University

231 total trials

What the finished NCT01907126 record still lists

NCT01907126 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 747-participant average among 12 other Sexual Assault trials with a reported enrollment target (94% lower).

The record links to 4 conditions, with Sexual Assault appearing as the primary indexed condition, and to 2 interventions - of which Nutrition Program (NP) is the first listed.

NCT01907126 reports a single indexed study location in Massachusetts, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01907126 about?

NCT01907126 is a clinical study titled "HIV/STI Risk Reduction for Incarcerated Women With Interpersonal Violence". The pilot study aims to conduct a randomized pilot trial in a sample of 40 incarcerated women with lifetime interpersonal violence who are 6-10 weeks away from release to demonstrate the feasibility and acceptability of the proposed recruitment methods and research design, of the intervention traini...

What is the current status of trial NCT01907126?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2011-09. Estimated completion is 2014-10.

What conditions does trial NCT01907126 study?

This clinical trial studies the following conditions: Sexual Assault, Unsafe Sex, Sexual Abuse, Physical Violence.

What interventions are being tested in trial NCT01907126?

The interventions under investigation include: Nutrition Program (NP) (BEHAVIORAL), Women's Prison CoOp (WPC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01907126?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01907126 being conducted?

This trial has 3 study locations across Massachusetts, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sexual Assault

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01907126's enrollment target sits among peer trials

42 11th of 12 higher than 2 of 12 other Sexual Assault trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sexual Assault trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01907126, the US trial registry maintained by the National Library of Medicine. NCT01907126 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.